M
Mahwash Mukhtar
Researcher at University of Szeged
Publications - 26
Citations - 444
Mahwash Mukhtar is an academic researcher from University of Szeged. The author has contributed to research in topics: Drug delivery & Medicine. The author has an hindex of 6, co-authored 20 publications receiving 126 citations. Previous affiliations of Mahwash Mukhtar include Quaid-i-Azam University.
Papers
More filters
Journal ArticleDOI
Nanomaterials for Diagnosis and Treatment of Brain Cancer: Recent Updates
Mahwash Mukhtar,Muhammad Bilal,Abbas Rahdar,Mahmood Barani,Rabia Arshad,Tapan Behl,Ciprian Brisc,Florin Banica,Simona Bungau +8 more
TL;DR: Light is shed on the current progress of various kinds of nanomaterials, such as liposomes, nano-micelles, dendrimers, carbon nanotubes, carbon dots and NPs, for efficient drug delivery in the treatment and diagnosis of brain cancer.
Journal ArticleDOI
Recent Advances in Nanotechnology-Based Diagnosis and Treatments of Human Osteosarcoma
TL;DR: This review invokes the possible utility of engineered nanomaterials in OSA diagnosis and treatment, motivating the researchers to seek new strategies for tackling the challenges associated with it.
Journal ArticleDOI
Progress in the Application of Nanoparticles and Graphene as Drug Carriers and on the Diagnosis of Brain Infections.
TL;DR: In this paper, the authors reviewed traditional diagnosis tools and key nanoparticles (Au-NPs, graphene, carbon nanotubes (CNTs), QDs, etc.) for early diagnosis of brain infections and meningitis.
Journal ArticleDOI
Glycyrrhizic acid-loaded pH-sensitive poly-(lactic-co-glycolic acid) nanoparticles for the amelioration of inflammatory bowel disease.
TL;DR: GA-loaded Eudragit S100/poly-(lactic-co-glycolic acid) nanoparticles could efficiently deliver GA to the colon and ameliorate the mucosal inflammation for a prolonged duration.
Journal ArticleDOI
Aerodynamic properties and in silico deposition of isoniazid loaded chitosan/thiolated chitosan and hyaluronic acid hybrid nanoplex DPIs as a potential TB treatment.
Mahwash Mukhtar,Edina Pallagi,Ildikó Csóka,Edit Benke,Árpád Farkas,Mahira Zeeshan,Katalin Burián,Dávid Kókai,Rita Ambrus +8 more
TL;DR: Biocompatible polymers with the ability to naturally recognize and bind to the surface receptors of alveolar macrophages, the reservoir of the causative organism, were selected and verified the suitability of DPIs for in-vivo tuberculosis therapeutics.